Drug Discovery and Development in the Cloud

By Bruce Maches

May 21, 2010

I hope that all of you have found the information in my blog so far to be of use to you out there. I have received a comment or two regarding potential approaches in dealing with public cloud validation and will provide an update on that topic in a future entry.

So far we have covered some basic facts on the life sciences companies and the regulatory environment they must exist in. I also explored some of the validation issues around using infrastructure related cloud technologies. In this entry I will start to guide you through the basic steps of drug discovery and development at a high level and point out areas where cloud computing can be leverage to facilitate the drug R&D process, reduce costs, and speed time to market. There is obviously a very broad topic and there is no way to effectively cover this subject in just one blog entry so this theme will be the core of the next several posts.

The pharmaceutical R&D process is a long and arduous procedure lasting up to 10 years or longer. It is also tremendously expensive with some new medications costing up to a billion to get from concept to market. There are a variety of factors that impact the cost and duration of the development effort. A few examples are: if a drug is a new one or a different indication (use) for an existing one, what therapeutic area it is targeted for (cancer, diabetes, etc), and what pathway or disease mechanism is the drug addressing. Given all of these factors, the drug development process can be very risky with many potential new drugs never making it to market after consuming hundreds of millions of dollars in research and development efforts. Industry figures vary but on average only 1 compound out of 5,000 or more make it from concept/discovery through development to the market place.

In layman’s terms, the drug development process can be broken into the following high-level activities:

  • Understanding the targeted disease mechanism within the body.
  • Finding a compound that will disrupt or modify that mechanism, initial FDA filing (patent clock is now ticking!).
  • Drug formulation, toxicity studies, and animal safety studies.
  • Initial human testing, further development work, dosing studies.
  • Large scale clinical testing for effectiveness and side effects.
  • Applying to the FDA for market approval.
  • Post approval monitoring.

Many of the applications used to support these pieces of the R&D process can be very compute and storage intensive making them great candidates for moving into the cloud. Given the nature of the drug development process, requirements for compute and storage resources can vary widely with huge peaks in demand as individual experiments or protocols are executed. This makes a strong case for cloud computing as the cost and time necessary to acquire and deploy these types of systems is simply prohibitive for many life science firms. Small companies clearly do not have the budget or resources available to provision these resources internally, and larger firms are dealing with on-going budget constraints with their R&D expenditures. Cloud computing is well suited for ‘bursty’ types of applications as the resources required can be provisioned on demand and at a much lower cost, reducing capital and operational expenses. Also, using cloud significantly cuts the time required to provision and qualify these resources, allowing life science companies to bring their products to market more quickly.

For this post I will concentrate on the up front set of activities around discovery and screening of new compounds and provide some examples of the different aspects of life sciences research that would benefit from the use of cloud computing.

A very commonly used technique in the biotech field is genomic sequencing, which is an extremely data and computationally intensive process. The technology involves looking for specific amino acid sequences in proteins or DNA samples. The amount of data generated is immense with many experimental runs producing gigabytes of data. All of this data has to be managed, stored and made available for follow on research and analysis. One of the applications used in this field is a piece of software called Basic Local Alignment Search Tool, or BLAST. This tool compares amino acid patterns in the sample being analyzed to a library of nucleotides looking for matches to certain sequences. This type of application is well suited to run in the cloud utilizing CPU and storage resources and then bring the results back to the researcher for further study. Tools such as Amazon’s Elastic Cloud Computing and Simple Storage Service (S3) are prime examples of offerings in this area. In addition, Amazon, along with other vendors, maintains copies of many of the publicly-available data sets on genomic and sequence data and makes them available to their clients as part of their overall cloud environment.

Another promising advance in the drug research process is what is called ‘in silico’ or virtual screening. The promise of virtual screening is that it will allow researchers to greatly increase the pace of finding new potential compounds while reducing costs for lab work and clinical trials. The screening process involves using an automated tool to test thousands of compounds for specific activity, either the inhibition or stimulation of a biochemical or biological mechanism. Running these tests requires the preparation of large numbers of assay plates each with hundreds or thousands of tiny wells. Compounds to be tested are placed in the wells using a pipette mechanism, processed by robotic labs and the corresponding reaction recorded. Using this high throughput technique allows researchers to screen thousands to millions of compounds but it can be costly and time consuming. Virtual screening provides the ability to model the desired reaction using tools such as the protein docking algorithm EADock greatly reducing the number of compound combinations needed to be tested. Leveraging cloud resources to perform ‘in silico’ testing will also cut costs and speed time to market.

Other potential applications for cloud computing include research areas such as protein docking simulations, data mining, and molecular modeling. I will reserve those areas for a future entry.

IT organizations supporting life science R&D functions should work towards creating a service based model for how they provide the resources required for these computational and storage thirsty applications. By understanding the underlying cost models and providing clear standards on how/when/where cloud infrastructure will be deployed, the IT group can better be able to properly manage and secure cloud based resources.

Continued advances in the field of drug discovery will exponentially increase the amount of data generated during the discovery process. IT organizations or vendors that can supply the needed cloud based infrastructure services in a secure and reliable manner will certainly do well in this space. Cloud computing also provides significant flexibility to the researcher as they are now free to explore avenues of research that would not have been feasible before the advent of cloud computing.

Cloud computing is certainly expanding its footprint in the life sciences community. The speed, efficiency and cost effectiveness have made cloud computing an indispensible tool for researchers, allowing them to focus on the ‘what’ of science and not the ‘how.’ Having the resources to do better research at this phase of the drug development process will also reduce time and expense in the later phases. My next post will expand further on the challenges and opportunities in the discovery phase of the pharmaceutical research process.

I would love to hear from you if you have any questions or comments. Feel free to contact me at [email protected].

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

At SC19: Bespoke Supercomputing for Climate and Weather

November 20, 2019

Weather and climate applications are some of the most important uses of HPC – a good model can save lives, as well as billions of dollars. But many weather and climate models struggle to run efficiently in their HPC en Read more…

By Oliver Peckham

Microsoft, Nvidia Launch Cloud HPC Service

November 20, 2019

Nvidia and Microsoft have joined forces to offer a cloud HPC capability based on the GPU vendor’s V100 Tensor Core chips linked via an InfiniBand network scaling up to 800 graphics processors. The partners announced Read more…

By George Leopold

Hazra Retiring from Intel Data Center Group, Successor Not Known

November 20, 2019

Rajeeb Hazra, corporate VP of Intel’s Data Center Group and GM for the Enterprise and Government Group, is retiring after more than 24 years at the company. At this writing, his successor is unknown. An earlier story on... Read more…

By Doug Black

Jensen Huang’s SC19 – Fast Cars, a Strong Arm, and Aiming for the Cloud(s)

November 20, 2019

We’ve come to expect Nvidia CEO Jensen Huang’s annual SC keynote to contain stunning graphics and lively bravado (with plenty of examples) in support of GPU-accelerated computing. In recent years, AI has joined the s Read more…

By John Russell

SC19 Student Cluster Competition: Know Your Teams

November 19, 2019

I’m typing this live from Denver, the location of the 2019 Student Cluster Competition… and, oh yeah, the annual SC conference too. The attendance this year should be north of 13,000 people, with the majority attende Read more…

By Dan Olds

AWS Solution Channel

Making High Performance Computing Affordable and Accessible for Small and Medium Businesses with HPC on AWS

High performance computing (HPC) brings a powerful set of tools to a broad range of industries, helping to drive innovation and boost revenue in finance, genomics, oil and gas extraction, and other fields. Read more…

IBM Accelerated Insights

Data Management – The Key to a Successful AI Project

 

Five characteristics of an awesome AI data infrastructure

[Attend the IBM LSF & HPC User Group Meeting at SC19 in Denver on November 19!]

AI is powered by data

While neural networks seem to get all the glory, data is the unsung hero of AI projects – data lies at the heart of everything from model training to tuning to selection to validation. Read more…

Top500: US Maintains Performance Lead; Arm Tops Green500

November 18, 2019

The 54th Top500, revealed today at SC19, is a familiar list: the U.S. Summit (ORNL) and Sierra (LLNL) machines, offering 148.6 and 94.6 petaflops respectively, remain in first and second place. The only new entrants in t Read more…

By Tiffany Trader

At SC19: Bespoke Supercomputing for Climate and Weather

November 20, 2019

Weather and climate applications are some of the most important uses of HPC – a good model can save lives, as well as billions of dollars. But many weather an Read more…

By Oliver Peckham

Hazra Retiring from Intel Data Center Group, Successor Not Known

November 20, 2019

Rajeeb Hazra, corporate VP of Intel’s Data Center Group and GM for the Enterprise and Government Group, is retiring after more than 24 years at the company. At this writing, his successor is unknown. An earlier story on... Read more…

By Doug Black

Jensen Huang’s SC19 – Fast Cars, a Strong Arm, and Aiming for the Cloud(s)

November 20, 2019

We’ve come to expect Nvidia CEO Jensen Huang’s annual SC keynote to contain stunning graphics and lively bravado (with plenty of examples) in support of GPU Read more…

By John Russell

Top500: US Maintains Performance Lead; Arm Tops Green500

November 18, 2019

The 54th Top500, revealed today at SC19, is a familiar list: the U.S. Summit (ORNL) and Sierra (LLNL) machines, offering 148.6 and 94.6 petaflops respectively, Read more…

By Tiffany Trader

ScaleMatrix and Nvidia Launch ‘Deploy Anywhere’ DGX HPC and AI in a Controlled Enclosure

November 18, 2019

HPC and AI in a phone booth: ScaleMatrix and Nvidia announced today at the SC19 conference in Denver a joint offering that puts up to 13 petaflops of Nvidia DGX Read more…

By Doug Black

Intel Debuts New GPU – Ponte Vecchio – and Outlines Aspirations for oneAPI

November 17, 2019

Intel today revealed a few more details about its forthcoming Xe line of GPUs – the top SKU is named Ponte Vecchio and will be used in Aurora, the first plann Read more…

By John Russell

SC19: Welcome to Denver

November 17, 2019

A significant swath of the HPC community has come to Denver for SC19, which began today (Sunday) with a rich technical program. As is customary, the ribbon cutt Read more…

By Tiffany Trader

SC19’s HPC Impact Showcase Chair: AI + HPC a ‘Speed Train’

November 16, 2019

This year’s chair of the HPC Impact Showcase at the SC19 conference in Denver is Lori Diachin, who has spent her career at the spearhead of HPC. Currently deputy director for the U.S. Department of Energy’s (DOE) Exascale Computing Project (ECP), Diachin is also... Read more…

By Doug Black

Supercomputer-Powered AI Tackles a Key Fusion Energy Challenge

August 7, 2019

Fusion energy is the Holy Grail of the energy world: low-radioactivity, low-waste, zero-carbon, high-output nuclear power that can run on hydrogen or lithium. T Read more…

By Oliver Peckham

Using AI to Solve One of the Most Prevailing Problems in CFD

October 17, 2019

How can artificial intelligence (AI) and high-performance computing (HPC) solve mesh generation, one of the most commonly referenced problems in computational engineering? A new study has set out to answer this question and create an industry-first AI-mesh application... Read more…

By James Sharpe

Cray Wins NNSA-Livermore ‘El Capitan’ Exascale Contract

August 13, 2019

Cray has won the bid to build the first exascale supercomputer for the National Nuclear Security Administration (NNSA) and Lawrence Livermore National Laborator Read more…

By Tiffany Trader

DARPA Looks to Propel Parallelism

September 4, 2019

As Moore’s law runs out of steam, new programming approaches are being pursued with the goal of greater hardware performance with less coding. The Defense Advanced Projects Research Agency is launching a new programming effort aimed at leveraging the benefits of massive distributed parallelism with less sweat. Read more…

By George Leopold

AMD Launches Epyc Rome, First 7nm CPU

August 8, 2019

From a gala event at the Palace of Fine Arts in San Francisco yesterday (Aug. 7), AMD launched its second-generation Epyc Rome x86 chips, based on its 7nm proce Read more…

By Tiffany Trader

D-Wave’s Path to 5000 Qubits; Google’s Quantum Supremacy Claim

September 24, 2019

On the heels of IBM’s quantum news last week come two more quantum items. D-Wave Systems today announced the name of its forthcoming 5000-qubit system, Advantage (yes the name choice isn’t serendipity), at its user conference being held this week in Newport, RI. Read more…

By John Russell

Ayar Labs to Demo Photonics Chiplet in FPGA Package at Hot Chips

August 19, 2019

Silicon startup Ayar Labs continues to gain momentum with its DARPA-backed optical chiplet technology that puts advanced electronics and optics on the same chip Read more…

By Tiffany Trader

Crystal Ball Gazing: IBM’s Vision for the Future of Computing

October 14, 2019

Dario Gil, IBM’s relatively new director of research, painted a intriguing portrait of the future of computing along with a rough idea of how IBM thinks we’ Read more…

By John Russell

Leading Solution Providers

ISC 2019 Virtual Booth Video Tour

CRAY
CRAY
DDN
DDN
DELL EMC
DELL EMC
GOOGLE
GOOGLE
ONE STOP SYSTEMS
ONE STOP SYSTEMS
PANASAS
PANASAS
VERNE GLOBAL
VERNE GLOBAL

Intel Confirms Retreat on Omni-Path

August 1, 2019

Intel Corp.’s plans to make a big splash in the network fabric market for linking HPC and other workloads has apparently belly-flopped. The chipmaker confirmed to us the outlines of an earlier report by the website CRN that it has jettisoned plans for a second-generation version of its Omni-Path interconnect... Read more…

By Staff report

Cray, Fujitsu Both Bringing Fujitsu A64FX-based Supercomputers to Market in 2020

November 12, 2019

The number of top-tier HPC systems makers has shrunk due to a steady march of M&A activity, but there is increased diversity and choice of processing compon Read more…

By Tiffany Trader

Kubernetes, Containers and HPC

September 19, 2019

Software containers and Kubernetes are important tools for building, deploying, running and managing modern enterprise applications at scale and delivering enterprise software faster and more reliably to the end user — while using resources more efficiently and reducing costs. Read more…

By Daniel Gruber, Burak Yenier and Wolfgang Gentzsch, UberCloud

Dell Ramps Up HPC Testing of AMD Rome Processors

October 21, 2019

Dell Technologies is wading deeper into the AMD-based systems market with a growing evaluation program for the latest Epyc (Rome) microprocessors from AMD. In a Read more…

By John Russell

Rise of NIH’s Biowulf Mirrors the Rise of Computational Biology

July 29, 2019

The story of NIH’s supercomputer Biowulf is fascinating, important, and in many ways representative of the transformation of life sciences and biomedical res Read more…

By John Russell

Xilinx vs. Intel: FPGA Market Leaders Launch Server Accelerator Cards

August 6, 2019

The two FPGA market leaders, Intel and Xilinx, both announced new accelerator cards this week designed to handle specialized, compute-intensive workloads and un Read more…

By Doug Black

When Dense Matrix Representations Beat Sparse

September 9, 2019

In our world filled with unintended consequences, it turns out that saving memory space to help deal with GPU limitations, knowing it introduces performance pen Read more…

By James Reinders

With the Help of HPC, Astronomers Prepare to Deflect a Real Asteroid

September 26, 2019

For years, NASA has been running simulations of asteroid impacts to understand the risks (and likelihoods) of asteroids colliding with Earth. Now, NASA and the European Space Agency (ESA) are preparing for the next, crucial step in planetary defense against asteroid impacts: physically deflecting a real asteroid. Read more…

By Oliver Peckham

  • arrow
  • Click Here for More Headlines
  • arrow
Do NOT follow this link or you will be banned from the site!
Share This